Cheng S, Gao L, Lu J, Hu Y, Wang Y, He H, Li J, Liu S, Yang F, Wu X, Fan L, Fan J, Yao Y, Sun Y, Li B, Zhang Y, Wu S, Cheng C, Xiao P, Ribeiro RC, Shaoyan H. Venetoclax combined with escalating doses of homoharringtonine, low-dose cytarabine, and granulocyte colony-stimulating factor demonstrates feasibility and tolerability for remission induction in pediatric acute myeloid leukemia. haematol [Internet]. 2020Sep.10 [cited 2025Mar.10];. Available from: https://haematologica.org/article/view/11967